Cargando…
Central Retinal Vein Occlusion after mRNA COVID-19 Vaccination
A 47-year-old man presented with visual loss in the right eye 8 h after the first dose of a coronavirus disease 2019 (COVID-19) vaccine developed by Pfizer/BioNTech (BNT162b2). The best corrected visual acuity (BCVA) was 20/200. Fundus examination showed dilated and tortuous retinal veins at the pos...
Autores principales: | Ishiguro, Kiyona, Hirano, Yoshio, Esaki, Yuya, Yasukawa, Tsutomu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293943/ https://www.ncbi.nlm.nih.gov/pubmed/37383170 http://dx.doi.org/10.1159/000530697 |
Ejemplares similares
-
Multimodal Imaging of Microvascular Abnormalities in Retinal Vein Occlusion
por: Hirano, Yoshio, et al.
Publicado: (2021) -
Morphologic Classifications and Locations of Microaneurysms and Clinical Relevance in Branch Retinal Vein Occlusion
por: Esaki, Yuya, et al.
Publicado: (2020) -
Severe Macular Ischemia Is Associated with a Poor Visual Prognosis and Serious Complications in Eyes with Central Retinal Vein Occlusion
por: Kurobe, Ryo, et al.
Publicado: (2023) -
Comment on: Central retinal vein occlusion after mRNA SARS-CoV-2 vaccination
por: Panigrahi, Pradeep K
Publicado: (2022) -
Microaneurysms cause refractory macular edema in branch retinal vein occlusion
por: Tomiyasu, Taneto, et al.
Publicado: (2016)